Want to join the conversation?
Electronic instrument maker $AME posted a decline in its 1Q16 results, hurt by weak oil and gas businesses. $AME said its diluted earnings per share dropped 10% from 1Q15. $AME posted 1Q16 net income of $134MM, or $0.57 per share compared to $142MM or $0.59 per share during 1Q15. Revenue came in at $944.4MM, down 4%.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.